Bcl-2 Rabbit Polyclonal Antibody
Usd: 315 Special Discount
Specification
Catalog# ER0602
Bcl-2 Rabbit Polyclonal Antibody
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
Human
-
unconjugated
Safety datasheet
Overview
Product Name
Bcl-2 Rabbit Polyclonal Antibody
Antibody Type
Rabbit Polyclonal Antibody
Immunogen
Synthetic peptide within N-terminal human Bcl-2.
Species Reactivity
Human
Validated Applications
WB, IF-Cell, IHC-P, FC
Molecular Weight
Predicted band size: 26 kDa
Positive Control
Jurkat cell lysate, HL-60 cell lysate, THP-1 cell lysate, Hela, human colon carcinoma tissue, human tonsil tissue.
Conjugation
unconjugated
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Immunogen affinity purified.
Application Dilution
-
WB
-
1:5,000
-
IF-Cell
-
1:200
-
IHC-P
-
1:200
-
FC
-
1:50-1:100
Target
Function
Damage to the Bcl-2 gene has been identified as a cause of a number of cancers, including melanoma, breast, prostate, chronic lymphocytic leukemia, and lung cancer, and a possible cause of schizophrenia and autoimmunity. It is also a cause of resistance to cancer treatments. Antibodies to Bcl-2 can be used with immunohistochemistry to identify cells containing the antigen. In healthy tissue, these antibodies will react with B-cells in the mantle zone, as well as some T-cells. However, there is a considerable increase in positive cells in follicular lymphoma, as well as many other forms of cancer. In some cases, the presence or absence of Bcl-2 staining in biopsies may be significant for the patient's prognosis or likelihood of relapse.
Background References
1. Li J., Y"BNIPL-2, a novel homologue of BNIP-2, interacts with Bcl-2 and Cdc42GAP in apoptosis." Qin W., Hu J., Guo M., Xu J., ao G., Zhou X., Jiang H., Zhang P., Shen L., Wan D., Gu J. Biochem. Biophys. Res. Commun. 308:379-385(2003)
2. "The flexible loop of Bcl-2 is required for molecular interaction with immunosuppressant FK-506 binding protein 38 (FKBP38)." Kang C.B., Tai J., Chia J., Yoon H.S. FEBS Lett. 579:1469-1476(2005)
3. "An inhibitor of Bcl-2 family proteins induces regression of solid tumours." Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., Bruncko M., Deckwerth T.L., Dinges J., Hajduk P.J., Joseph M.K., Kitada S., Korsmeyer S.J., Kunzer A.R., Letai A., Li C., Mitten M.J., Nettesheim D.G. Rosenberg S.H. Nature 4
Sequence Similarity
Belongs to the Bcl-2 family.
Tissue Specificity
Expressed in a variety of tissues.
Post-translational Modification
Phosphorylation/dephosphorylation on Ser-70 regulates anti-apoptotic activity. Growth factor-stimulated phosphorylation on Ser-70 by PKC is required for the anti-apoptosis activity and occurs during the G2/M phase of the cell cycle. In the absence of growth factors, BCL2 appears to be phosphorylated by other protein kinases such as ERKs and stress-activated kinases. Phosphorylated by MAPK8/JNK1 at Thr-69, Ser-70 and Ser-87, wich stimulates starvation-induced autophagy. Dephosphorylated by protein phosphatase 2A (PP2A) (By similarity).; Proteolytically cleaved by caspases during apoptosis. The cleaved protein, lacking the BH4 motif, has pro-apoptotic activity, causes the release of cytochrome c into the cytosol promoting further caspase activity.; Monoubiquitinated by PRKN, leading to increase its stability. Ubiquitinated by SCF(FBXO10), leading to its degradation by the proteasome.
Subcellular Location
Mitochondrion outer membrane, Nucleus membrane, Endoplasmic reticulum membrane, Cytoplasm.
UNIPROT
Synonyms
Apoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
ExpandApoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
D630044D05Rik antibody
D830018M01Rik antibody
Leukemia/lymphoma, B-cell, 2 antibody
Oncogene B-cell leukemia 2 antibody
PPP1R50 antibody
Protein phosphatase 1, regulatory subunit 50 antibody
Bcl 2 antibody
CollapseImages
-
Western blot analysis of Bcl-2 on different lysates with Rabbit anti-Bcl-2 antibody (ER0602) at 1/5,000 dilution.
Lane 1: Jurkat cell lysate
Lane 2: HL-60 cell lysate
Lane 3: THP-1 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 26 kDa
Observed band size: 26 kDa
Exposure time: 1 minute 2 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ER0602) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:50,000 dilution was used for 1 hour at room temperature. -
ICC staining Bcl-2 in Hela cells (green). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
-
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue using anti-Bcl-2 rabbit polyclonal antibody. Counter stained with hematoxylin.
-
Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-Bcl-2 rabbit polyclonal antibody. Counter stained with hematoxylin.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
The Receptor Activator of Nuclear Factor κB Ligand (RANKL) Regulates the Biological Behavior of Trophoblasts through the PI3K/Akt Signaling Pathway
Journal: Placenta
DOI: 10.1016/j.placenta.2026.01.001
IF: 2.5
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Liuwei Dihuang Pills Suppress Hepatocellular Carcinoma via PI3K/AKT/TP53 Pathway: Integrating Network Pharmacology, Metabolomics, and Experimental Validation
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2026.157780
IF: 8.3
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Co-exposure to polystyrene nanoplastics and hexachlorocyclohexane induces enhanced human sperm toxicity in vitro
Journal: Reproductive Toxicology
DOI: 10.1016/j.reprotox.2026.109201
IF: 2.8
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation
Journal: Bioorganic Chemistry
DOI: 10.1016/j.bioorg.2025.109210
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Alkannin triggered apoptosis and ferroptosis in gastric cancer by suppressing lipid metabolism mediated by the c-Fos/SREBF1 axis
Journal: Phytomedicine
DOI: 10.1016/j.phymed.2025.156604
IF: 6.7
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
Palmatine ameliorates intestinal epithelial barrier injury in ulcerative colitis via targeting enolase 3
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115110
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Ursolic and oleanolic acids suppress MNNG induced malignant transformation of human gastric mucosal epithelium by regulating the PI3 K/AKT pathway
Journal: Scientific Reports
DOI: 10.1038/s41598-025-03606-3
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
Dual-functional copper nanoplatform potentiates cuproptosis through p53 reactivation and metabolic reprogramming
Journal: Journal of Colloid and Interface Science
DOI: 10.1016/j.jcis.2025.139625
IF: 9.7
Application: WB
Reactivity: Human
Publish date: 2025 Dec
-
Identification and Analysis of Microplastic Aggregation in CAR-T Cells
Journal: Journal Of Hazardous Materials
DOI:
IF: 12.2
Application: WB
Reactivity: Mouse
Publish date: 2024 Nov
-
HNRNP I promotes IRAK1 degradation to reduce podocyte apoptosis and inflammatory response alleviating renal injury in diabetic nephropathy
Journal: Immunobiology
DOI:
IF: 2.5
Application: WB
Reactivity: Human
Publish date: 2024 Jul
-
Nobiletin Ameliorates Aging of Chicken Ovarian Prehierarchical Follicles by Suppressing Oxidative Stress and Promoting Autophagy
Journal: Cells
DOI: 10.3390/cells13050415
IF: 5.1
Application: WB
Reactivity: Chicken
Publish date: 2024 Feb
-
Atroposelective Synthesis of Biaryl N-Oxides via Cu-Catalyzed De Novo Heteroaromatic N-Oxide Ring Formation
Journal: Advanced Science
DOI: 10.1002/advs.202405743
IF: 14.3
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
FOXO1 reshapes neutrophils to aggravate acute brain damage and promote late depression after traumatic brain injury
Journal: Military Medical Research
DOI:
IF: 21.1
Application: WB
Reactivity: Mouse
Publish date: 2024 Apr
-
Potential role of Bcl2 in lipid metabolism and synaptic dysfunction of age-related hearing loss
Journal: Neurobiology Of Disease
DOI:
IF: 6.1
Application: WB
Reactivity: Rat
Publish date: 2023 Oct
-
Elucidation of the anti-colon cancer mechanism of Phellinus baumii polyphenol by an integrative approach of network pharmacology and experimental verification
Journal: International Journal Of Biological Macromolecules
DOI:
IF: 8.2
Application: WB
Reactivity: Human
Publish date: 2023 Oct
-
Phellinus baumii Polyphenol: A Potential Therapeutic Candidate against Lung Cancer Cells
Journal: International Journal Of Molecular Sciences
DOI:
IF: 6.208
Application: WB
Reactivity: Human
Publish date: 2022 Dec
-
Inhibition of mu-opioid receptor suppresses proliferation of hepatocellular carcinoma cells via CD147-p53-MAPK cascade signaling pathway. American journal of translational research, 13(5), 3967–3986.
Journal: American Journal Of Translational Research
DOI:
IF: 4.06
Application: WB
Reactivity: Human
Publish date: 2021 May
-
Ethanolic extract of Cordyceps cicadae exerts antitumor effect on human gastric cancer SGC-7901 cells by inducing apoptosis,cell cycle arrest and endoplasmic reticulum stress.
Journal: Journal Of Ethnopharmacology
DOI:
IF: 3.115
Application: WB
Reactivity: Human
Publish date: 2019 Mar
Alternative Products
Products with the same target and pathway
Phospho-Bcl-2 (S70) Recombinant Rabbit Monoclonal Antibody [PSH11-02] - BSA and Azide free
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8]
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Recombinant Mouse Monoclonal Antibody [9F3-R]
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [SZ10-03] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [9F1]
Application: WB,IHC-P
Reactivity: Human
Conjugate: unconjugated
Phospho-Bcl-2 (S70) Recombinant Rabbit Monoclonal Antibody [PSH11-02]
Application: WB,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [9F3]
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Recombinant Mouse Monoclonal Antibody [9F3-R] - BSA and Azide free
Application: WB,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PSH09-49] - BSA and Azide free
Application: WB,IF-Cell,IHC-P,FC,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [SZ10-03]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PD01-41]
Application: WB,IHC-P,IF-Cell,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human
Conjugate: unconjugated
Bcl-2 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse
Conjugate: unconjugated
Bcl-2 Mouse Monoclonal Antibody [F7-1-A1]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
FITC Conjugated Bcl-2 Recombinant Rabbit Monoclonal Antibody [JF104-8]
Application: FC
Reactivity: Human,Mouse
Conjugate: FITC
Bcl-2 Recombinant Rabbit Monoclonal Antibody [PSH09-49]
Application: WB,IF-Cell,IHC-P,FC,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated